北京商报讯(记者 王寅浩 宋雨盈)11月10日,上海医药发布公告称,公司下属上海上药新亚药业有限公司收到国家药品监督管理局颁发的《药品补充申请批准通知书》,注射用头孢呋辛钠、注射用氨曲南通过仿制药质量和疗效一致性评价。公告显示,注射用头孢呋辛钠适用于治疗呼吸道感染、耳鼻喉感染、泌尿系感染等疾病中特定微生物敏感菌株引起的感染,最早于1978在英国、意大利等国家上市;注射用氨曲南适用于治疗尿路(复杂和...
Source Link北京商报讯(记者 王寅浩 宋雨盈)11月10日,上海医药发布公告称,公司下属上海上药新亚药业有限公司收到国家药品监督管理局颁发的《药品补充申请批准通知书》,注射用头孢呋辛钠、注射用氨曲南通过仿制药质量和疗效一致性评价。公告显示,注射用头孢呋辛钠适用于治疗呼吸道感染、耳鼻喉感染、泌尿系感染等疾病中特定微生物敏感菌株引起的感染,最早于1978在英国、意大利等国家上市;注射用氨曲南适用于治疗尿路(复杂和...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.